Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Hepatitis C Testing Market Grown from 2024 to 2025?

Over the past few years, the market size for hepatitis C testing has significantly amplified. Its growth is predicted to rise from $1.24 billion in 2024, to $1.32 billion in 2025, with a compound annual growth rate (CAGR) of 6.6%. The historic growth can be correlated with the increasing prevalence of hepatitis C, the enlargement of public health initiatives, the escalating use of intravenous drugs, heightened awareness regarding the risks of hepatitis C, and government grants aimed at controlling infectious diseases.

What Growth Rate Is Anticipated for the Hepatitis C Testing Market in the Coming Years?

Expectations are high for the hepatitis c testing market, with predictions suggesting substantial growth in the coming years. By 2029, the market is projected to amass a value of $1.68 billion, propelled by a compound annual growth rate (CAGR) of 6.2%. The expansion in the forecast period is as a result of factors such as the surge in demand for the initial detection of the disease, improved healthcare availability, increased focus on preventive health, support from leading global health organizations, and state-run initiatives aimed at eradicating hepatitis C. Significant trends that are associated with this forecast period encompass the application of multiplex diagnostic platforms, the incorporation of artificial intelligence (AI) into diagnostic instruments, a move towards home-based testing kits, enlarged cooperation for test formulation, and the creation of affordable testing solutions.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24559&type=smp

Who Are the Leading Companies in the Hepatitis C Testing Market?

Major companies operating in the hepatitis c testing market are F. Hoffmann-La Roche Ltd., Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Quest Diagnostics Incorporated, Hologic Inc., QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., SD Biosensor INC., QIAGEN N.V., DiaSorin S.p.A., Cepheid, Abcam Plc, OraSure Technologies Inc., Meridian Bioscience Inc., Trivitron Healthcare Private Limited, General Biologicals Corporation, Biogate Laboratories Ltd., Cosara Diagnostics Private Limited, BioGenex Life Sciences Private Limited, BIOGENIX INC. PVT. LTD.

What Are the Key Drivers of the Hepatitis C Testing Market?

The growth of the hepatitis C testing market is expected to be fuelled by the increasing prevalence of hepatitis cases. Hepatitis C is a viral infection that can cause severe liver damage if left untreated owing to inflammation. The lack of adequate vaccination rates, leaving many people vulnerable to the virus, is the primary reason for the increased hepatitis cases. Hepatitis C testing plays a crucial role in early virus detection, enabling immediate treatment to prevent severe liver damage and complications. Furthermore, it helps identify infected individuals, mitigating the spread of the virus and improving disease control. The World Health Organization (WHO), a Switzerland-based global public health intergovernmental organization, reported in April 2024 that over 50 million people worldwide are living with chronic hepatitis C virus infection. Roughly 1.0 million new infections are reported every year. Consequently, the surging prevalence of hepatitis cases is fuelling the growth of the hepatitis C testing market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=24559&type=smp

What Are the Key Market Segments in the Hepatitis C Testing Industry?

The hepatitis c testing market covered in this report is segmented –

1) By Type: Antibody Tests, Nucleic Acid Tests, Genotyping Tests

2) By Product: Test Kits, Instruments, Reagents, Consumables

3) By Technology: Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Diagnostic Tests, Polymerase Chain Reaction, Next-Generation Sequencing

4) By Application: Blood Screening, Viral Load Monitoring, Disease Diagnosis

5) By End-User: Hospital-Based Laboratories, Stand-Alone Laboratories, Other End-Users

Subsegments:

1) By Antibody Tests: Enzyme Immunoassay (EIA), Recombinant Immunoblot Assay (RIBA), Rapid Diagnostic Tests (RDTs)

2) By Nucleic Acid Tests (NATs): Quantitative Ribonucleic Acid (RNA) Tests, Qualitative Ribonucleic Acid (RNA) Tests, Transcription-Mediated Amplification (TMA), Reverse Transcription Polymerase Chain Reaction (RT-PCR)

3) By Genotyping Tests: Line Probe Assay (LiPA), Sequencing-Based Assay, Real-Time Polymerase Chain Reaction (PCR)-Based Genotyping

What Are the Latest Trends in the Hepatitis C Testing Market?

Prominent corporations within the hepatitis C testing market are concentrating on creating improved solutions such as dual antigen-antibody diagnostic assessments for more efficient screening and surveillance of the ailment. The dual antigen-antibody diagnostic examination identifies viral proteins (antigens) and immune response proteins (antibodies) to distinguish between active and previous infections. This methodology provides an in-depth analysis of the infection status. To put it in context, Roche Diagnostics India Pvt. Ltd., a diagnostic tests and systems enterprise based in India, unveiled the Elecsys HCV Duo in July 2023. This fully automated immunoassay can independently and simultaneously detect both HCV antibodies and antigens from a single plasma or serum sample. This revolutionary technique facilitates early detection, aids patient care, and is consistent with India’s national approach to eradicate hepatitis C through comprehensive and prompt screening.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/hepatitis-c-testing-global-market-report

What Are the Key Regional Markets in the Hepatitis C Testing Industry?

North America was the largest region in the hepatitis C testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepatitis c testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24559

This Report Delivers Insight On:

1. How big is the hepatitis c testing market, and how is it changing globally?

2. Who are the major companies in the hepatitis c testing market, and how are they performing?

3. What are the key opportunities and risks in the hepatitis c testing market right now?

4. Which products or customer segments are growing the most in the hepatitis c testing market?

5. What factors are helping or slowing down the growth of the hepatitis c testing market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model